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Background: Participation in daily physical activity (PA) has never been objectively assessed in
candidates for lung transplantation (LTx). The main research questions were: 1) How active are
LTx-candidates in daily life? 2) What are determinants of activity behavior before LTX?
Methods: Ninety-six candidates for LTx (diagnosis of COPD or interstitial lung disease; mean
age 55  7 years) underwent measurements of PA, pulmonary function, 6-min walking distance
(6MWD), muscle force and health-status (SF-36 scale).
Results: Patients were markedly inactive (5% of waking hours walking, 26% standing and 69%
sedentary). Backward multiple regression identified 6MWD (expressed as % of predicted value;
bZ 73.0 steps, partial r2Z 0.36, pZ 0.00), a higher score on the energy/fatigue scale of the
SF-36 (b Z 28.6 steps, partial r2 Z 0.09, p Z 0.00) and a higher expiratory muscle force (ex-
pressed as % of predicted value; bZ 11.8 steps, partial r2Z 0.05, pZ 0.02) as determinants
of daily steps. Minutes of mild to moderate (2 METs) activity were determined by 6MWD (ex-
pressed as % of predicted value; bZ 2.14 min, partial r2Z 0.30, pZ 0.00), inspiratory muscle
force (expressed as % of predicted value; b Z 0.33 min, partial r2 Z 0.04, p Z 0.05) and
seasonal influences (spring/summer vs. autumn/winter: b Z 18.95 min, partial r2 Z 0.04,
p Z 0.05). The overall fit of the models was r2 Z 0.50 and r2 Z 0.38, respectively.s of Respiratory Rehabilitation and Respiratory Division, University Hospital Leuven, Leuven, Belgium.
er.kuleuven.be (R. Gosselink).
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748 D. Langer et al.Conclusions: The 6MWD was the main determinant of an inactive lifestyle in these patients.
Respiratory muscle force, energy and fatigue and seasonal variations explained some addi-
tional variability in activity behavior. Patients should be encouraged to participate in interven-
tions aimed at improving physical fitness and participation in daily physical activity before LTx.
ª 2012 Elsevier Ltd. All rights reserved.Background
Lung transplantation (LTx) is an ultimate treatment option
for patients with chronic lung diseases whose life expec-
tancy after the intervention is exceeding the predicted
survival without treatment.1 According to data from the
registry of the International Society for Heart and Lung
Transplantation (ISHLT) the overall unadjusted survival of
patients is now 52% after five years.2 In the University
Hospital Leuven, the five-year survival has increased from
50% in the first years to about 75% in more recent years.3
Regardless of its effects on survival the intervention has
a positive impact on lung function, exercise capacity4 and
quality of life.5 Expected survival after transplantation
depends on prognostic variables of candidates for LTx such
as age, underlying diagnosis and exercise capacity, among
others.6,7
No study has so far objectively measured participation in
daily physical activity in a large group of candidates for
LTx. Current recommendations from the American College
of Sports Medicine and the American Heart Association on
the type and amount of physical activity needed to improve
health in adults aged 50e64 with clinically significant
chronic conditions especially stress the importance of
reducing sedentary behavior in these subjects.8 Reducing
the risk for type 2 diabetes mellitus and hypertension are
among the health benefits that can be achieved by reducing
sedentary behavior.8 This seems to be of particular rele-
vance in candidates for LTx regarding the high prevalence
of morbidities such as hypertension, diabetes and dyslipi-
demia that will be exacerbated by the use corticosteroids
and other immunosuppressive medicines in these patients
after the transplantation.
The first aim of this study was therefore to objectively
assess levels of physical activity in candidates for LTx. In
a second step we aimed to identify determinants of
participation in daily physical activity with a special focus
on variables that might be modified to reduce sedentary
behavior before LTx.Methods
Subjects and design
Ninety-six candidates for LTx (56% women), 69 with chronic
obstructive pulmonary disease (COPD) and 27 with inter-
stitial lung disease (ILD) were included in this cross-
sectional study between July 2005 and August 2009. All
patients were on the active waiting list for either single or
double LTx. Patients were not included if they were
candidates for multiple organ transplantation, youngerthan 40 years, or if they had been scheduled for re-
transplantation due to graft dysfunction. Younger patients
that are mainly suffering from cystic fibrosis were excluded
from the current analysis since they supposedly have
profiles of daily activity that are very different from the
patients that were included in the current project. The
study was approved by the Ethics Committee of the
University Hospital Leuven and all subjects gave informed
consent to participate in the study.
Daily physical activity
Daily physical activity was assessed with two activity
monitors. Both monitors were worn simultaneously on 4
consecutive days during 12 waking hours. Patients were
instructed not to change their daily routine while wearing
the devices. None of the individuals participated in any
supervised exercise training program during activity moni-
toring days. Thirty patients started participating in a pre-
transplant rehabilitation program after the screening tests
for this study had been performed.
The DynaPort Activity Monitor (McRoberts BV, The
Hague, NL) quantifies time spent in different postures, time
spent walking or cycling, daily steps and movement inten-
sity during walking. A detailed description of the device can
be found elsewhere.9,10
The SenseWear Pro monitor (SenseWear, Body Media,
Pittsburgh, US) quantifies the energy expenditure during
physical activities. Time spent in activities above 2 METs
(mild to moderate intensity) was used as the main outcome.
Both activity monitors were previously validated in patients
with COPD.11e13 Daily average values over the four-day
period were calculated for all physical activity parameters.
Determinants of physical activity
The Medical Outcomes Study Short Form (SF-36) question-
naire was used to evaluate different domains of health-
related quality of life (HRQoL). The survey consists of eight
scales that are covering different domains of mental health
and physical health.14 The SF-36 was previously validated in
patients with COPD15 and has been used in patients before
and after LTx.16e19
The Hospital Anxiety and Depression Scale (HADS) was
designed to identify and quantify the two most common
forms of psychological disorders in medical patients.20
Scores range from 0 to 21 for both subscales. Total scores
in each category of 8 are interpreted as indicators of
clinically relevant symptoms of anxiety or depression.20
The HADS has previously been recommended for screening
purposes in patients with COPD21,22 and has also been used
in lung and heart-lung recipients.23,24
Table 1 Patient characteristics.
Complete sample
(n Z 96)
Patients with COPD
(n Z 69)
Patients with ILD
(n Z 27)
p-value
Mean  SD Mean  SD Mean  SD
Anthropometrics
Gender (M/F) 42/54 30/39 12/15 0.93
Age (yr) 55  7 56  5 51  10 0.01
Height (cm) 166  9 166  9 166  8 0.91
Weight (Kg) 64  16 63  16 66  17 0.49
BMI (Kg/m2) 22.8  5.0 22.4  4.6 23.7  6.0 0.28
Pulmonary function
FEV1 (L) 0.91  0.57 0.70  0.22 1.49  0.77 0.00
FEV1 (% pred) 33  20 25  6 54  29 0.00
FVC (L) 2.30  0.91 2.38  0.87 2.12  0.99 0.21
FVC (% pred) 67  21 70  18 61  26 0.09
Tiffeneau index 42  21 31  8 70  19 0.00
FRC (L) 5.03  2.24 5.94  1.73 2.84  1.81 0.00
FRC (% pred) 166  71 195  51 95  60 0.00
TLC (L) 6.40  2.19 7.18  1.71 4.33  1.93 0.00
TLC (% pred) 113  34 126  23 77  33 0.00
TLCO (% pred) 35  12 35  12 33  10 0.34
Exercise capacity
6MWD (m) 329  103 327  102 334  108 0.77
6MWD (% pred) 48  15 48  15 48  16 0.84
O2 during 6MWD (L) 1.0  1.3 0.8  1.1 1.5  1.7 0.04
Borg dyspnea score 6.5  2.5 6.7  2.7 6.3  2.1 0.54
Borg leg fatigue score 4.2  3.0 4.0  3.0 4.7  3.1 0.37
Muscle function
MIP (% pred) 78  28 74  25 87  33 0.03
MEP (% pred) 82  28 79  29 90  25 0.10
HGF (% pred) 86  19 89  18 79  18 0.02
QF (% pred) 74  19 74  19 74  20 0.90
SF-36 scale
Physical functioning 14  13 14  13 14  12 0.84
Role limitations physical 14  24 15  24 11  24 0.57
Role limitations emotional 60  44 62  44 56  45 0.61
Energy and fatigue 43  19 42  19 44  19 0.72
Emotional well-being 63  21 62  21 66  20 0.52
Social functioning 46  28 43  28 54  26 0.10
Bodily Pain 58  30 58  30 58  29 0.98
General Health 20  15 20  14 21  17 0.90
HAD scale
HADS anxiety 7.4  4.3 7.5  4.3 7.2  4.3 0.83
HADS depression 7.3  4.0 7.7  3.9 6.5  4.1 0.28
Physical Activity
Walking time (min) 34  19 32  21 37  16 0.38
Standing time (min) 188  82 189  84 187  77 0.96
Sitting time (min) 383  119 378  128 397  93 0.54
Lying time (min) 102  103 110  113 81  67 0.27
Other time (min) 13  5 11  5 18  4 0.00
Movement Intensity (m/s2) 1.8  0.3 1.8  0.2 1.9  0.3 0.43
Steps (n/day) 2928  1796 2844  1892 3158  1520 0.49
Minutes  2 METs 55  59 54  62 57  53 0.85
Definition abbreviations: BMIZ body mass index; FEV1Z forced expiratory volume in 1 s; FVCZ forced vital capacity; FRCZ functional
residual capacity; TLC Z total lung capacity; TLCO Z carbon monoxide diffusion capacity; Other time: cycling and undefined;
6MWD Z 6-min walking distance; MIP Z maximal inspiratory pressure; MEP Z maximal expiratory pressure; HGF Z handgrip force;
QF Z quadriceps force; SF-36 Z Short Form-36 Questionnaire; HADS Z Hospital Anxiety and Depression Scale; MET Z Metabolic
Equivalent. Values are expressed as mean  SD.
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750 D. Langer et al.Measurements of pulmonary function were performed
according to the guidelines of the European Respiratory
Society.25 Values are expressed both in absolute numbers
and as a percentage of the normal reference values, as
proposed by Quanjer et al.26
Recordings of maximal inspiratory and expiratory
pressures were performed as described by Black and
Hyatt27 and the normal values used were those proposed
by Rochester and Arora.28 Quadriceps force was assessed
on a Cybex Norm Dynamometer (Enraf Nonius, Delft, NL)
and normal values used were those reported by
Decramer.29 The handgrip force was measured using
a hydraulic hand dynamometer (Jamar Preston, Jackson,
MI, USA). Normal values were those proposed by Mathio-
wetz.30 Patients also completed an encouraged 6-min
walking distance (6MWD) test in a 50 m hospital corridor
that was compared to normal reference values established
in our laboratory.31
Since seasonal influences are known to influence
participation in daily physical activity32 the activity profiles
of patients assessed during the autumn/winter period
(October to March) were compared with the profiles of
those assessed during spring/summertime (April to
September). Other possible determinants of participation
in daily activity such as living arrangements (living alone or
with a partner/spouse), employment status, the presence
of co morbidities (Anxiety and Depression, left ventricular
dysfunction, and pulmonary hypertension) and the use of
long-term oxygen therapy were retrieved from the hospital
records.Statistical analysis
Data were analyzed with SPSS version 13 statistical
package (SPSS Inc., Chicago, IL, USA). Descriptive statis-
tics were calculated for all variables and reported as
mean  SD for quantitative variables and as proportions
for categorical variables unless reported otherwise.
Baseline measurements were compared between patients
with COPD and ILD using unpaired t-tests or chi-square
tests. Pearson correlation coefficients were calculated to
test linear associations between variables. A stepwise
backward multiple regression analysis was performed to
identify independent contributors to the variance in daily
activity. The following approach was taken to select
variables that were entered into the multivariate model.
In a first step all predictors that were significantly related
to daily activity (continuous variables) in the single
correlation analyses or that showed significant differences
in daily activity between categories (dichotomous vari-
ables) were selected. In a second step other factors that
were hypothesized to be related to activity behavior based
on theoretical assumptions and results of previous
research32 were entered into the model. The backward
stepwise regression method used begins by entering all
terms specified on the stepwise list into the model. At
each step, the least significant stepwise term is removed
from the model until all of the remaining stepwise terms
have a statistically significant contribution to the model. A
p-value of <0.05 was considered as threshold for statis-
tical significance.Results
Subjects
Characteristics of 96 candidates for LTx and the two
subsamples of underlying diseases causing the organ failure
(COPD n Z 69 and ILD n Z 27) are summarized in Table 1.
The majority of patients with ILD were diagnosed with
idiopathic pulmonary fibrosis (n Z 17). Other diagnoses
included extrinsic allergic alveolitis (n Z 4), sarcoidosis
(n Z 3), lymphangioleiomyomatosis (n Z 1), eosinophilic
granuloma (n Z 1), and pulmonary fibrosis due to mixed
connective tissue disease (n Z 1).
Typical differences in the pattern of their severe
pulmonary function impairment were apparent between
patients with ILD and patients with COPD (Table 1). Limi-
tations in gas exchange were comparable between groups.
Candidates for LTx were found to be markedly inactive
in daily life. On average only 5% of waking hours were spent
walking and 26% of this time was spent standing. The major
part of the waking hours was devoted to sedentary behav-
iors [sitting (54%) and lying (15%)]. A detailed profile of
daily physical activity is provided in Table 1.
The average 6MWD of patients was reduced by 52% in
comparison to reference values. On the modified Borg scale
patients reported more symptoms of dyspnea in comparison
with symptoms of leg fatigue upon termination of the test
(Table 1). Both respiratory and peripheral muscle force
were substantially lower than normal values. This reduction
was most pronounced in leg muscles (26% reduction in
comparison with predicted normal values; Table 1).
In comparison with reference values from the Dutch
general population,33 domains of the SF-36 related to
mental health were less impaired than scores on the
physical health subscales.34
Daily physical activities of 47 patients were assessed
during the autumn/winter period (OctobereMarch) and 48
patients were assessed during spring/summertime
(AprileSeptember). Forty-three patients (43% in the COPD
group and 56% of ILD patients) were receiving long term
oxygen therapy. The majority of patients (75%) lived
together with a partner. Sixteen patients were still
working. Most of them reported to perform mainly admin-
istrative (sitting) tasks during their working hours. Thirty
four percent of patients showed symptoms of depression or
anxiety (HAD-scale score of 8). Signs of left ventricular
dysfunction or pulmonary hypertension were diagnosed in
12% and 14% of the patients, respectively.
Determinants of participation in daily physical
activity
Pulmonary function was only weakly related to participation
in daily physical activity. For a given limitation in pulmonary
function a considerable variability in daily physical activity
was found (Fig. 1). Daily steps ranged from 405 steps (corre-
sponding to about 5 min of walking) to 7575 steps (approxi-
mately 80 min of daily walking). In line with the large
variability in daily physical activity we found also exercise
capacity to be highly variable in our patient cohort (6MWD
ranging from 14% to 83% of the predicted normal value).
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Figure 1 Scatter plots of limitations in (a) FEV1 and (b) diffusion capacity for carbon monoxide (TLCO) against participation in
daily physical activity (daily steps) in patients with COPD (closed circles) and patients with ILD (open circles).
Physical activity in lung transplant candidates 751Of all measured variables the 6MWD showed the stron-
gest association with participation in daily physical activity.
Good correlations between 6MWD and both minutes in
activities  2 METs and number of steps were observed.
Representative scatter plots of the associations between
these variables are presented in Fig. 2.
Moderate associations between maximal expiratory
pressures (expressed as a percentage of the predicted
normal value) and both minutes in activities  2 METs
(R Z 0.27, p Z 0.01), and number of steps (R Z 0.27,
p Z 0.02) were observed. Physical functioning (SF-36) was
related to both energy expenditure  2 METs (R Z 0.32,
p Z 0.01) and number of steps per day (R Z 0.40,
p Z 0.001). No correlations between mental health scales
of the SF-36 and daily physical activity were observed. Co
morbidities (pulmonary hypertension or left ventricular
dysfunction) and employment status were also not found to
be related to activity in daily life.
The effects of seasonal variation, the use of long term
oxygen therapy, symptoms of depression and living
arrangements are summarized in Fig. 3. Significant differ-
ences in daily activity levels were found for the use of long
term oxygen therapy and seasonal variations. While the
average number of daily steps was similar in both parts of
the year (autumn/winter: 2766  1688 steps, spring/
summer: 3046  1923 steps, p Z 0.19) the time spent in
activities  2 METs was significantly higher in spring/0 10 20 30 40 50 60 70 80 90
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Figure 2 Scatter plots of 6-min walking distance (6MWD) agains
activities requiring  2 METs. Closed circles represent patients witsummer (64  66 min vs. 49  46 min, pZ 0.02). Both daily
steps (3362  1812 steps vs. 2440  1700 steps, pZ 0.023)
and time in activities  2 METs (78  72 min vs. 34  30 min,
p < 0.001) were significantly higher in patients who were
not oxygen dependent in comparison with those who were
on long-term oxygen therapy. Based on results of the single
correlation analyses and comparisons between different
levels of dichotomous variables the following nine param-
eters were entered into the multivariate model: TLCO,
maximal inspiratory pressure, maximal expiratory pressure,
6MWD, physical functioning (SF-36), energy and fatigue (SF-
36), social functioning (SF-36), seasonal variation, and long
term oxygen therapy. FEV1 and Quadriceps Force were
added to these variables since they had been shown to be
related to daily activity in previous studies. When these 11
potential facilitators and barriers to participation in daily
physical activity were entered into a backward multiple
regression model the 6MWD (expressed as % of predicted
normal value; bZ 73.0 steps, partial r2Z 0.36, pZ 0.00),
a higher score on the energy/fatigue scale of the SF-36
(b Z 28.6 steps, partial r2 Z 0.09, p Z 0.00) and
a higher expiratory muscle force (expressed as % of pre-
dicted normal value; b Z 11.8 steps, partial r2 Z 0.05,
p Z 0.02) emerged as significant determinants of daily
steps. The overall fit of the model was r2 Z 0.50. Deter-
minants of daily minutes  2 METs were besides 6MWD
(expressed as % of predicted normal value; b Z 2.14 min,10 20 30 40 50 60 70 80 90
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Figure 3 The effects of seasonal variation, the use of long
term oxygen therapy (LTOT), symptoms of depression and
living arrangements on participation in daily physical activity.
Minutes > 2 METs Z daily time spent in activities requiring an
intensity of at least 2 metabolic equivalents. * Z p < 0.05.
752 D. Langer et al.partial r2 Z 0.30, p Z 0.00) and inspiratory muscle force
(expressed as % of predicted normal value; b Z 0.33 min,
partial r2 Z 0.04, p Z 0.05) also whether measurements
were conducted in the spring/summer vs. the autumn/
winter period of the year (bZ 18.95 min, partial r2Z 0.04,
p Z 0.05). The overall model fit was r2 Z 0.38. Pulmonary
function, the use of long-term oxygen therapy, peripheral
muscle force, mental health, living arrangements, the
presence of co-morbidities and employment status did not
contribute to any of the two models.Conclusions
This is the first study that objectively assessed participation
in daily physical activity in a large group of candidates for
LTx with an underlying diagnosis of either COPD or ILD. In
addition potential determinants of activity behavior were
evaluated. Candidates for LTx above the age of 40 were
markedly inactive in daily life and showed severe reduc-
tions in functional exercise capacity and both respiratory
and peripheral muscle force. In univariate analyses func-
tional exercise capacity, respiratory muscle force, the use
of long term oxygen therapy, self-reported physical func-
tioning and seasonal variations were all related to partici-
pation in daily physical activity while limitations in
pulmonary function, the presence of co-morbidities,
mental health, living arrangements and employment
status were not. In a multivariate model lower functional
exercise capacity emerged as the strongest determinant of
participation in daily physical activity. Respiratory muscle
force, levels of self-reported energy and fatigue and
seasonal variation explained additional variation in activity
behavior.
Candidates for LTx in the current study (average age
55  7 yrs) were more inactive than patients with COPD not
listed for LTx (average age 67  7 yrs) that were studied
previously in our center.10 Candidates for LTx presented an
additional reduction of 23% in daily walking time and were
spending 24 additional minutes in sedentary behavior
(sitting or lying) during daily waking hours in comparison
with these patients despite of being on average 12 yearsyounger.10 Still there existed a large variability in physical
fitness and participation in daily activity in these candi-
dates for LTx (Fig. 1).
Identifying functional exercise capacity (6MWD) as the
strongest determinant of participation in daily physical
activity is in line with previous findings in patients with
COPD.10,35 Exercise capacity seems to be most strongly
related to participation in daily activity in patients with
more pronounced reductions in their 6MWD (60% of pre-
dicted normal values). Taking into account that exercise
capacity in candidates for LTx was on average 23% below
the values that had previously been observed in patients
with COPD not listed for LTx8 it comes as no surprise that
limitations in exercise capacity emerged as an important
predictor of activity behavior.
It was however surprising to find mental health not to
be related to participation in daily activity. One explana-
tion for this might be the relatively low prevalence of
symptoms of anxiety or depression (34%) in this population
in comparison with similar patient populations.36,37 In
patients with end-stage COPD a prevalence of symptoms of
mood disorders of up to 90% had been reported.36 The
lower prevalence in candidates for LTx might be explained
by the fact that patients are anticipating improvements in
health status after the transplantation. A prevalence of
clinically relevant symptoms of anxiety or depression of
more than 50% was previously reported in Iranian patients
on the LTx waiting list.37 The lower prevalence of mood
disorders in the current sample might be due to exclusion
of patients with severe mood disorders after an initial
psychological screening or differences in cultural
background.
Self-reported physical functioning and the use of long
term oxygen therapy were strongly related with activity
behavior in the univariate analyses but were not contrib-
uting as independent determinants in a multivariate model.
Both variables were strongly correlated with the perfor-
mance on the 6MWD-test and were therefore probably not
independently contributing to the prediction model. In line
with this it was remarkable to identify seasonal variation as
an independent determinant of activity behavior even in
this very sedentary population.
Even though a large part of the variability in participa-
tion in daily activity could be explained still half of the
variation in activity behavior remained unexplained.
Several other environmental and behavioral factors that
are known to be related to participation in daily physical
activity, such as expected health benefits, self-efficacy,
social support and access to facilities32 were not assessed in
this research project. These variables might explain addi-
tional variability in activity behavior and should be taken
into account in future studies in this population.Clinical implications
Reducing the amount of sedentary behavior before trans-
plantation should be an important treatment goal with
regard to reducing the burden of co-morbidity both before
and after LTx. Identifying modifiable risk factors for
sedentary behavior was a therefore an important goal of
the current study.
Physical activity in lung transplant candidates 753Functional exercise capacity (6MWD) emerged as the
strongest determinant of activity behavior in LTx candi-
dates. Pulmonary rehabilitation including structured exer-
cise training has been shown to be an effective intervention
to improve functional exercise capacity, respiratory muscle
force and quality of life even in patients with severe
COPD.38,39 Improvements that can be achieved in candi-
dates for LTx will very likely have a positive impact on
recovery after transplantation. This is also supported by
data from Martinu et al. in which the pre-transplant 6MWD
was identified as an important predictor of post-transplant
survival.6 Effects of interventions directly targeting activity
behavior have already been studied in various healthy and
non-healthy populations.40 These interventions were
effective in reducing sedentary behavior by increasing daily
walking time by an average of almost 30%.40
In conclusion, efforts should be undertaken to combine
exercise training interventions that improve exercise
capacity and respiratory muscle force in patients with
COPD or ILD who are candidates for LTx with interventions
that aim to increase participation in daily activity. Future
intervention studies should provide information as to
whether sedentary behavior before LTx can be reduced and
if this eventually will translate into favorable health effects
both before and after LTx.Conflict of interest
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